[Occupational acute mercury intoxication--a case report].
The aim of this paper is to present a case of acute occupational mercury poisoning treated at the Clinical Department of Occupational Diseases. A welder, forty years old was employed at a large chemical plant in the dissembling department involved in the production of acetaldehyde. The patient was referred to the hospital by an occupational physician. During his shift; dissembling mercury-covered tubes a nausea, abdominal pain and elevated temperature occurred. He was also complaining of headache and symptoms of gingivitis, which lasted two weeks before hospitalization. Before admission to the Clinical Department, mercury concentrations in urine were measured twice. The urine mercury levels were very high, impossible to determine precisely. During hospitalization, the patient was complaining of head and gingiva pains. Since the symptoms persisted and high urine mercury levels (830 micrograms/l) were determined--DMPS--Heyl was administered. After treatment symptoms subsided and the concentration of mercury in urine was gradually returning to normal. The results of laboratory tests did not reveal any impairment of internal organs. Consultant in neurology found the presence of nystagmus and positive Romberg test in the patient. Neurological signs disappeared after a month. The measurements performed by the Department of Work Safety revealed high exceeded hygiene permissible limits of mercury vapors in the air. The information provided by the employer's technical services also showed that the patient was working with the face mask, but its absorber was not readjusted to mercury vapors. A control ambulatory examination (one and a half year later) did not reveal health effects of acute exposure to mercury vapors.
Złotkowska
Renata
R
Zakładu Epidemiologii, Oddziału Chorób Zawodowych, Instytutu Medycyny Pracy i Zdrowia Srodowiskowego w Sosnowcu. r-zlotkowska@imp.sosnowiec.pl
Zajac-Nedza
Maria
M
D000328:Adult; D000395:Air Pollutants, Occupational / Q000009:adverse effects*; D000931:Antidotes / Q000627:therapeutic use; D002614:Chelating Agents / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008628:Mercury / Q000009:adverse effects* / Q000652:urine; D008630:Mercury Poisoning / Q000188:drug therapy / Q000209:etiology*; D016273:Occupational Exposure / Q000009:adverse effects*; D013388:Succinimides / Q000627:therapeutic use; D013997:Time Factors; D016896:Treatment Outcome; D014896:Welding
D000395:Air Pollutants, Occupational; D000931:Antidotes; D002614:Chelating Agents; D013388:Succinimides; C064754:3-(3,5-dichlorophenyl)-1-methyl-2,5-pyrrolidinedione; D008628:Mercury